Skip to main content

Advertisement

ADVERTISEMENT

Volume 19 - Issue 4 - April, 2007

Feature

Original Contribution
08/01/2008
Shaoliang Chen, MD, Junjie Zhang, MD, Fei Ye, MD, Zhongsheng Zhu, MD, Song Lin, MD, Shoujie Shan, MD, Tak W. Kwan, MD
Shaoliang Chen, MD, Junjie Zhang, MD,...
Bifurcation lesions are still technically challenging, even in the era of modern drug-eluting stents (DES).1 Data on bare-metal stenting (BMS) did not demonstrate any advantages of the double-stent technique over single stenting because of a...
Bifurcation lesions are still technically challenging, even in the era of modern drug-eluting stents (DES).1 Data on bare-metal stenting (BMS) did not demonstrate any advantages of the double-stent technique over single stenting because of a...
Bifurcation lesions are still...
08/01/2008
Journal of Invasive Cardiology
Rapid Communication
08/01/2008
Edo Kaluski, MD, Steve Tsai, MD, *Olga Milo-Cotter, MD
Edo Kaluski, MD, Steve Tsai, MD, *O...
With conventional equipment and methodology, certain anatomic conditions preclude the ability to pass a guidewire, balloon, or stent into the diseased target segment. These rare conditions include unusual coronary anatomy, chronic total...
With conventional equipment and methodology, certain anatomic conditions preclude the ability to pass a guidewire, balloon, or stent into the diseased target segment. These rare conditions include unusual coronary anatomy, chronic total...
With conventional equipment and...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
Stéphane Cook, MD, Bernhard Meier, MD, Stephan Windecker, MD
Stéphane Cook, MD, Bernhard Meier, M...
Case Presentation. A 52-year-old female was admitted in cardiogenic shock 4 days after multivessel stenting and closure of a grade 3 patent foramen ovale (PFO) with a 25 mm Amplatzer occluder. Diagnostic catheterization was performed under...
Case Presentation. A 52-year-old female was admitted in cardiogenic shock 4 days after multivessel stenting and closure of a grade 3 patent foramen ovale (PFO) with a 25 mm Amplatzer occluder. Diagnostic catheterization was performed under...
Case Presentation. A 52-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Imad Sheiban, MD, Amedeo Chiribiri, MD, Serena Beninati, MD, Claudio Moretti, MD, Pierluigi Omedè, MD, Filippo Sciuto, MD, Walter Grosso Marra, MD, Giuseppe Biondi-Zoccai, MD, Mario Bollati, MD, Alfonso Gambino, MD, Gian Paolo Trevi, MD
Imad Sheiban, MD, Amedeo Chiribiri, M...
Significant in-stent restenosis (ISR), i.e., intrastent neo-intimal proliferation following bare-metal stent (BMS) implantation, which determines an angiographic and/or clinically significant stenosis,1 occurs with an incidence varying...
Significant in-stent restenosis (ISR), i.e., intrastent neo-intimal proliferation following bare-metal stent (BMS) implantation, which determines an angiographic and/or clinically significant stenosis,1 occurs with an incidence varying...
Significant in-stent restenosis...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Chi-Hang Lee, MBBS, Jimmy Lim, MBBS, Adrian Low, MBBS, Xiao-Ling Zhang, MD, Than-Than Kyaing, MD, Mark Y. Chan, MBBS, Hwee-Bee Wong, MSc, Yean-Teng Lim, MBBS, Huay-Cheem Tan, MBBS
Chi-Hang Lee, MBBS, Jimmy Lim, MBBS, ...
Drug-eluting stents (DES) have emerged as a novel technology in coronary revascularization. Ample evidence has shown that polymer-based DES effectively reduce in-stent restenosis and repeat revascularization after percutaneous coronary...
Drug-eluting stents (DES) have emerged as a novel technology in coronary revascularization. Ample evidence has shown that polymer-based DES effectively reduce in-stent restenosis and repeat revascularization after percutaneous coronary...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Aravinda Nanjundappa, MD, Sangeeta Mandapaka, MD, Robert S. Dieter, MD
Aravinda Nanjundappa, MD, Sangeeta Ma...
Acute coronary syndrome is one of the leading causes of morbidity and mortality in the United States, and afflicts 879,000 Americans each year.1 Percutaneous treatment of acute coronary syndrome is a well-accepted remedy for relief of...
Acute coronary syndrome is one of the leading causes of morbidity and mortality in the United States, and afflicts 879,000 Americans each year.1 Percutaneous treatment of acute coronary syndrome is a well-accepted remedy for relief of...
Acute coronary syndrome is one...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Shinichi Furuichi, MD, Giuseppe M. Sangiorgi, MD, Altin Palloshi, MD, Cosmo Godino, MD, Flavio Airoldi, MD, Matteo Montorfano, MD, Alaide Chieffo, MD, Iassen Michev, MD, Mauro Carlino, MD, Antonio Colombo, MD
Shinichi Furuichi, MD, Giuseppe M. Sa...
Lesions at coronary divisions, either bifurcation or trifurcation, represent a challenging area in interventional cardiology. Indeed, it has been shown that percutaneous coronary intervention (PCI) in this anatomical setting using bare-metal...
Lesions at coronary divisions, either bifurcation or trifurcation, represent a challenging area in interventional cardiology. Indeed, it has been shown that percutaneous coronary intervention (PCI) in this anatomical setting using bare-metal...
Lesions at coronary divisions,...
08/01/2008
Journal of Invasive Cardiology

Department

Letters to the Editor
08/01/2008
Professor Nicholas G. Kounis, MD, PhD, FESC, FACC, George N. Kounis, MD, MSc, *George D. Soufras, MD, PhD
Professor Nicholas G. Kounis, MD, PhD...
In the very interesting report1 and editorial2 published in the December 2006 issue of the Journal, the authors reported and commented on 13 patients who developed severe, diffuse coronary artery spasm after drug-eluting stent insertion. Five...
In the very interesting report1 and editorial2 published in the December 2006 issue of the Journal, the authors reported and commented on 13 patients who developed severe, diffuse coronary artery spasm after drug-eluting stent insertion. Five...
In the very interesting report1...
08/01/2008
Journal of Invasive Cardiology
Letters to the Editor
08/01/2008
Brigitta C. Brott, MD, FACC and William B. Hillegass, MD, MPH, FACC
Brigitta C. Brott, MD, FACC and Willi...
We thank Dr. Kounis and his colleagues for their comments regarding the link between coronary vasospasm, allergic reactions, and the use of drug-eluting stents. As their discussion points out, a hypersensitivity response to an allergen, such...
We thank Dr. Kounis and his colleagues for their comments regarding the link between coronary vasospasm, allergic reactions, and the use of drug-eluting stents. As their discussion points out, a hypersensitivity response to an allergen, such...
We thank Dr. Kounis and his...
08/01/2008
Journal of Invasive Cardiology
Addendum
08/01/2008
Spyros Kokolis, MD, Alan Feit, MD, Jonathan D. Marmur, MD
Spyros Kokolis, MD, Alan Feit, MD, J...
NULL
NULL
NULL
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement